Dermata Therapeutics's other assets is $430K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Dermata Therapeutics (DRMA) currently reports a other assets of $430K as of March 2026. That compares with $290K in the prior-year period — up 49.5% year over year. Use the charts on this page to explore Dermata Therapeutics's other assets history and peer comparisons.
Dermata Therapeutics's other assets increased from $290K to $430K — a 49.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Dermata Therapeutics reported $430K in other assets as of March 2026. That compares with $290K in the prior-year period — up 49.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other assets of $430K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dermata Therapeutics, and consider following DRMA for alerts when major investors trade the stock.
Dermata Therapeutics is classified in the Healthcare sector. On other assets, it currently shows $430K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DRMA with unrelated industries.